Cognitive Walking + Brain Stimulation for Older Adults

N/A

Recruiting

Led By David J Clark, ScD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

Summary

This trial aims to test if using a combination of cognitive walking exercises and electrical brain stimulation can help older adults improve their cognitive and walking functions. The study will compare the effects of real brain stimulation with fake

Who is the study for?

This trial is for older adults, aged 65 and above, who have noticed a decline in their memory or cognitive abilities over the past year. Participants should be able to walk on their own for six minutes, even if they need to use a cane.

What is being tested?

The study is looking at whether walking exercises that make you think combined with electrical brain stimulation can help improve brain function in older adults. It compares real electrical stimulation of the brain's prefrontal area with fake (sham) stimulation.

What are the potential side effects?

Possible side effects from the non-invasive electrical brain stimulation may include mild itching, tingling on the scalp, brief discomfort or fatigue. Walking exercise is generally safe but could potentially cause muscle soreness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention (an average of 6 weeks after baseline), follow-up (an average of 12 weeks after post-intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

score on test of executive function

walking speed for obstacle task negotiation task

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Walking Exercise plus active tDCSActive Control2 Interventions

The walking exercise will focus on use of complex walking tasks such as obstacle crossing, accurate foot placement, and walking on compliant surfaces. Each session will consist of 30 minutes of walking. Active tDCS will be delivered over prefrontal cortex.

Group II: Walking Exercise plus sham tDCSPlacebo Group2 Interventions

The walking exercise will focus on use of complex walking tasks such as obstacle crossing, accurate foot placement, and walking on compliant surfaces. Each session will consist of 30 minutes of walking. Sham tDCS will be delivered over prefrontal cortex.

Do I qualify?Apply below to find out